AU2020335909A1 - System for regulating gene expression - Google Patents

System for regulating gene expression Download PDF

Info

Publication number
AU2020335909A1
AU2020335909A1 AU2020335909A AU2020335909A AU2020335909A1 AU 2020335909 A1 AU2020335909 A1 AU 2020335909A1 AU 2020335909 A AU2020335909 A AU 2020335909A AU 2020335909 A AU2020335909 A AU 2020335909A AU 2020335909 A1 AU2020335909 A1 AU 2020335909A1
Authority
AU
Australia
Prior art keywords
polya
seq
aptamer
nucleic acid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020335909A
Other languages
English (en)
Inventor
Jocelyn Duen-Ya JEA
Liming LUO
Laising Yen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU2020335909A1 publication Critical patent/AU2020335909A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2020335909A 2019-08-30 2020-08-28 System for regulating gene expression Pending AU2020335909A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962894611P 2019-08-30 2019-08-30
US62/894,611 2019-08-30
US201962904635P 2019-09-23 2019-09-23
US62/904,635 2019-09-23
US202063043504P 2020-06-24 2020-06-24
US63/043,504 2020-06-24
PCT/US2020/048561 WO2021041924A2 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Publications (1)

Publication Number Publication Date
AU2020335909A1 true AU2020335909A1 (en) 2022-04-14

Family

ID=74683442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020335909A Pending AU2020335909A1 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Country Status (11)

Country Link
US (1) US20220290147A1 (cg-RX-API-DMAC10.html)
EP (1) EP4022065A4 (cg-RX-API-DMAC10.html)
JP (2) JP7737152B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220049619A (cg-RX-API-DMAC10.html)
CN (1) CN115279902A (cg-RX-API-DMAC10.html)
AU (1) AU2020335909A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022003512A2 (cg-RX-API-DMAC10.html)
CA (1) CA3152513A1 (cg-RX-API-DMAC10.html)
IL (1) IL290944A (cg-RX-API-DMAC10.html)
MX (1) MX2022002390A (cg-RX-API-DMAC10.html)
WO (1) WO2021041924A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769991C2 (ru) 2015-11-12 2022-04-12 Байлор Колледж Оф Медсин Экзогенный контроль экспрессии генов млекопитающих с помощью опосредованной аптамерами модуляции полиаденилирования
US20260053851A1 (en) 2021-08-11 2026-02-26 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
EP1733034A4 (en) 2004-03-15 2010-01-20 Biogen Idec Inc METHOD AND CONSTRUCTS FOR THE EXPRESSION OF POLYPEPTIDE MULTIMERS IN EUKARYONTIC CELLS USING ALTERNATIVE SPLEISSEN
US20050282190A1 (en) * 2004-04-09 2005-12-22 Hua Shi Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, RNA scaffolds, their expression, and methods of use
CA2566286A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
US7825229B2 (en) * 2005-03-25 2010-11-02 Rosetta Genomics Ltd. Lung cancer-related nucleic acids
US8178503B2 (en) * 2006-03-03 2012-05-15 International Business Machines Corporation Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
US20150284738A1 (en) * 2006-12-29 2015-10-08 Rodina Holding S.A. Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
US20130157279A1 (en) * 2010-09-01 2013-06-20 Nec Corporation Method for detecting target substance and aptamer set, sensor, and apparatus used in the method
US20130239236A1 (en) * 2010-10-01 2013-09-12 R1 B3 Holdings B.V. Regulation of translation of expressed genes
EP2812436A4 (en) * 2012-02-10 2016-05-11 Univ Leland Stanford Junior MINI-INTRONIC PLASMID VECTORS
WO2013173637A1 (en) * 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
US9567581B2 (en) * 2012-08-07 2017-02-14 The General Hospital Corporation Selective reactivation of genes on the inactive X chromosome
WO2016126747A1 (en) 2015-02-02 2016-08-11 Meiragtx Uk Limited Regulation of gene expression by aptamer-mediated modulation of alternative splicing
CA2979229A1 (en) * 2015-03-11 2016-09-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rp2 vectors for treating x-linked retinitis pigmentosa
RU2769991C2 (ru) * 2015-11-12 2022-04-12 Байлор Колледж Оф Медсин Экзогенный контроль экспрессии генов млекопитающих с помощью опосредованной аптамерами модуляции полиаденилирования

Also Published As

Publication number Publication date
JP7737152B2 (ja) 2025-09-10
EP4022065A4 (en) 2024-02-14
WO2021041924A2 (en) 2021-03-04
CA3152513A1 (en) 2021-03-04
CN115279902A (zh) 2022-11-01
JP2025118711A (ja) 2025-08-13
EP4022065A2 (en) 2022-07-06
US20220290147A1 (en) 2022-09-15
BR112022003512A2 (pt) 2022-05-17
KR20220049619A (ko) 2022-04-21
JP2022546408A (ja) 2022-11-04
MX2022002390A (es) 2022-05-13
IL290944A (en) 2022-04-01
WO2021041924A3 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
US12415994B2 (en) Synthetic miniature Crispr-Cas (CasMINI) system for eukaryotic genome engineering
WO2019067872A1 (en) COMPOSITIONS AND METHODS FOR EDITING THE TTR GENE AND TREATING AMYLOID DOSE ATTR
CN106572974A (zh) 用于将分子有效递送到细胞的具有脂质聚集体的组合物和方法
JP2002525066A (ja) 核酸の特異的な細胞の局在化のための転写法
US20230383275A1 (en) Sgrna targeting aqp1 rna, and vector and use thereof
JP2025118711A (ja) 遺伝子発現を調節するためのシステム
CN116783295A (zh) 指导rna的新型设计及其用途
CN107012158B (zh) 一种端粒酶启动基因表达方法及其应用
KR20250158036A (ko) 리보자임-매개 rna 조립 및 발현
WO2024040202A1 (en) Fusion proteins and uses thereof for precision editing
JP2025514304A (ja) 遺伝子治療法のための組織特異的遺伝子外セーフハーバーの同定
WO2026045988A1 (zh) 反向引导编辑系统
CN119789877A (zh) 一种可用于筛选针对rna重复序列药物的报告系统
RU2825581C1 (ru) Система регуляции экспрессии генов
US20240067957A1 (en) Autocatalytic base editing for rna-responsive translational control
Douzandegan et al. Optimization of kyse-30 esophagus cancer cell line transfection using lipofectamine 2000
JP4709971B2 (ja) 細胞内へ核酸を導入する為の新規な分子並びに細胞内へ導入する核酸および細胞内へ核酸を導入する為の新規な方法
KR20260046119A (ko) 단방향 유전자 삽입 동안 도입유전자 발현을 증진시키는 bGH-SV40L 직렬 PolyA의 용도
WO2025184186A1 (en) Excision of exon 53 for treatment of duchenne muscular dystrophy
EP4490291A1 (en) Precise excisions of portions of exons for treatment of duchenne muscular dystrophy
WO2025072763A2 (en) Compositions and methods for precision editing with cas dimers
WO2023164482A2 (en) Treatment for nucleotide repeat expansion disease
EA048813B1 (ru) Композиции и способы редактирования гена ttr и лечения транстиретинового амилоидоза (attr)
EA053115B1 (ru) Полинуклеотиды, композиции и способы редактирования генома
HK40032638B (en) Polynucleotides, compositions, and methods for genome editing